title: What is the role of roflumilast in chronic obstructive pulmonary disease?
authors.affiliation: Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA. lauc@ccf.org.
authors.forename: Chris
authors.initials: C
authors.lastname: Lau
authors.affiliation: Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA.|Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
authors.forename: Atul C
authors.initials: AC
authors.lastname: Mehta
authors.affiliation: Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA.|Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
authors.forename: Umur
authors.initials: U
authors.lastname: Hatipoglu
mesh_terms: D000631:Aminopyridines / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000378:metabolism; D003521:Cyclopropanes / Q000009:adverse effects / Q000627:therapeutic use; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D058988:Phosphodiesterase 4 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic
chemical_list: D000631:Aminopyridines; D001549:Benzamides; D003521:Cyclopropanes; D058988:Phosphodiesterase 4 Inhibitors; C424423:Roflumilast; D000242:Cyclic AMP